Company announces PIPE financing of up to $122 m
Browsing: All news
Category Added in a WPeMatico Campaign
Part of $27 million fund to foster collaboration
New Alzheimer’s drug data highlights increased
Study identifies the nuclear protein Pin1 as piv
Seed round led by SV Health and Two Bear Capital
Study shows Shingrix vaccine may delay dementia
Cognition Therapeutics reports once-daily drug’s potential to slow Alzheimer’s progression, showing promise with favorable safety profile. Cognition Therapeutics, Inc. recently disclosed findings from their Phase 2 SHINE trial, investigating the efficacy of CT1812, an experimental oral treatment for Alzheimer’s disease.…
Recent study indicates that hyperbaric oxygen th
New research highlights inconsistency in lifespa
Crossbench peer urges UK Parliament to consider